Nanologica (NICA) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
20 May, 2026Executive summary
Net sales for Q1 2026 reached SEK 21.5 million, up from SEK 10.8 million year-over-year, mainly due to the Syntagon acquisition.
Operating profit was SEK 66.5 million, significantly impacted by SEK 78.9 million in negative goodwill from the Syntagon acquisition.
Profit before tax was SEK 65.2 million, compared to a loss of SEK 10.2 million in Q1 2025.
Cash and cash equivalents increased to SEK 39.3 million as of March 31, 2026.
The acquisition of Syntagon and successful share issues have strengthened operational capacity and financial position.
Financial highlights
Net sales: SEK 21,456 thousand (Q1 2025: SEK 10,751 thousand).
Operating profit: SEK 66,484 thousand (Q1 2025: SEK -9,241 thousand), driven by non-recurring negative goodwill.
Earnings per share: SEK 0.72 (Q1 2025: SEK -0.14).
Cash flow from operating activities: SEK -6,862 thousand (Q1 2025: SEK -19,194 thousand).
Equity: SEK 97,496 thousand (Q1 2025: SEK 63,940 thousand).
Outlook and guidance
Large-scale silica production is stable, enabling larger deliveries and improved margins.
The acquisition of Syntagon is expected to contribute positively to earnings and cash flow from 2026.
Increased focus on sales and business development, especially for Syntagon.
Good opportunities for continued sales growth in silica media for chromatography.
Latest events from Nanologica
- Acquisition and capital raise set stage for accelerated growth and improved profitability in 2026.NICA
Q4 202526 Feb 2026 - Sales surged and losses narrowed as stable production enabled new market orders and product launches.NICA
Q3 202523 Oct 2025 - Sales grew in H1, but Q2 losses deepened; production gains and new orders signal optimism.NICA
Q2 202510 Jul 2025 - Sales growth and new orders offset by deepening losses and major asset write-downs.NICA
Q3 202413 Jun 2025 - Strong sales growth and narrowed losses position Nanologica for ambitious 2024 targets.NICA
Q2 202413 Jun 2025 - Record sales and narrowed losses set the stage for strong growth in 2025.NICA
Q1 20256 Jun 2025 - Record sales and improved liquidity set the stage for Nanologica's growth in chromatography.NICA
Q4 20245 Jun 2025